These findings suggest that while p300 activity may be important for the development of butyrate resistance in (at least some) CRC cell lines, it is not absolutely required, and that p300-independent mechanisms also play a role (Fig. 4). The gene discussed is EP300; the disease is colorectal carcinoma.